𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer

✍ Scribed by Klaus Sahora; Irene Kuehrer; Martin Schindl; Claus Koelblinger; Peter Goetzinger; Michael Gnant

Publisher
Springer
Year
2011
Tongue
English
Weight
226 KB
Volume
35
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant docetaxel treatment for loca
Neoadjuvant docetaxel treatment for locally advanced prostate cancer : A clinicopathologic study
✍ Cristina Magi-Galluzzi; Ming Zhou; Alwyn M. Reuther; Robert Dreicer; Eric A. Kle πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

## Abstract ## BACKGROUND. The objective of the current study was to determine the histologic and molecular changes that occurred in patients with high‐risk, localized prostate cancer (PCa) after neoadjuvant docetaxel chemotherapy. ## METHODS. Patients who had locally advanced PCa (serum preoper

Neoadjuvant strategies for the treatment
Neoadjuvant strategies for the treatment of locally advanced esophageal cancer
✍ John R. Hyngstrom; Mitchell C. Posner πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local‐regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized